Cleared Traditional

K940933 - 9267 SPO2 ATHENA MODULE

K940933 is an FDA 510(k) clearance for 9267 SPO2 ATHENA MODULE, manufactured by S & W Medico Teknik. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Traditional 510(k) pathway after a 639-day FDA review.

K940933 · S & W Medico Teknik · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1995
Decision
639d
Days
Class 2
Risk

K940933 is an FDA 510(k) clearance for the 9267 SPO2 ATHENA MODULE. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by S & W Medico Teknik (Denmark, DK). The FDA issued a Cleared decision on November 29, 1995 after a review of 639 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all S & W Medico Teknik devices

FDA 510(k) Submission Details - K940933

510(k) Number K940933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 1994
Decision Date November 29, 1995
Days to Decision 639 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
499d slower than avg
Panel avg: 140d · This submission: 639d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 502
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K940933.
3304 PULSE OXIMETER
K962156 · Bci Intl., Inc. · Aug 1996
SCORE SOFTWARE
K961450 · Nellcor Puritan Bennett, Inc. · Aug 1996
OXITEMP, 3301T SA
K960058 · Bci Intl., Inc. · May 1996
OXILINK (SMALL, MEDIUM, LARGE)
K953126 · Bci Intl., Inc. · Sep 1995
NELLCOR SYMPHONY N-3000 PULSE OXIMETER
K952316 · Nellcor, Inc. · Aug 1995
NELLCOR N-20PA PORTABLE PULSE OXIMETER
K952222 · Nellcor, Inc. · Aug 1995